United States · FDA National Drug Code directory

Nicotine Mini

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83253-262_02c97791-c232-426b-b818-f38a532822b2
Product NDC
83253-262
Form
LOZENGE
Composition / generic term
nicotine polacrilex
Labeler
HC Jones, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20230430
Source listing expiry
20271231

Source-listed ingredients

  • NICOTINE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 4 BOTTLE, PLASTIC in 1 BOX (83253-262-18) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 83253-262-18
  • 27 LOZENGE in 1 BOTTLE, PLASTIC (83253-262-27) · 83253-262-27
  • 3 BOTTLE, PLASTIC in 1 BOTTLE (83253-262-81) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 83253-262-81

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →